Evidence map›Paper›PMID 28915250›Full record

ArticlePloS one2017

Multi-layered mutation in hedgehog-related genes in Gorlin syndrome may affect the phenotype.

Shoko Onodera, Akiko Saito, Daigo Hasegawa, Nana Morita, Katsuhito Watanabe, Takeshi Nomura, Takahiko Shibahara, Shinsuke Ohba, Akira Yamaguchi, Toshifumi Azuma

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed, 1 pooled it
1.9field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 1 synthesis or guideline pooled it, 27 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Review
  9. Review
  10. NovelCase reports in genetics · 2019
    Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 1 country.

Shoko OnoderaDepartment of Biochemistry, Tokyo Dental College, Tokyo, Japan.ORCID http://orcid.org/0000-0003-0673-3400
Akiko SaitoDepartment of Biochemistry, Tokyo Dental College, Tokyo, Japan.
Daigo HasegawaDepartment of Oral and Maxillofacial Surgery, Tokyo Dental College, Tokyo, Japan.
Nana MoritaDepartment of Oral Medicine, Oral and Maxillofacial Surgery, Tokyo Dental College, Chiba, Japan.
Katsuhito WatanabeDepartment of Oral and Maxillofacial Surgery, Tokyo Dental College, Tokyo, Japan.
Takeshi NomuraDepartment of Oral Medicine, Oral and Maxillofacial Surgery, Tokyo Dental College, Chiba, Japan.
Takahiko ShibaharaDepartment of Oral and Maxillofacial Surgery, Tokyo Dental College, Tokyo, Japan.
Shinsuke OhbaDivision of Clinical Biotechnology, The University of Tokyo Graduate School of Medicine, Bunkyo-ku, Tokyo, Japan; Department of Bioengineering, The University of Tokyo Graduate School of Engineering, Bunkyo-ku, Tokyo, Japan.
Akira YamaguchiOral health science center, Tokyo Dental College, Tokyo, Japan.
Toshifumi AzumaDepartment of Biochemistry, Tokyo Dental College, Tokyo, Japan.
Tokyo Dental College · JPThe University of Tokyo · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Gorlin syndrome is a genetic disorder of autosomal dominant inheritance that predisposes the affected individual to a variety of disorders that are attributed largely to heterozygous germline patched1 (PTCH1) mutations. PTCH1 is a hedgehog (Hh) receptor as well as a repressor, mutation of which leads to constitutive activation of Hh pathway. Hh pathway encompasses a wide variety of cellular signaling cascades, which involve several molecules; however, no associated genotype-phenotype correlations have been reported. Recently, mutations in Suppressor of fused homolog (SUFU) or PTCH2 were reported in patients with Gorlin syndrome. These facts suggest that multi-layered mutations in Hh pathway may contribute to the development of Gorlin syndrome. We demonstrated multiple mutations of Hh-related genes in addition to PTCH1, which possibly act in an additive or multiplicative manner and lead to Gorlin syndrome. High-throughput sequencing was performed to analyze exome sequences in four unrelated Gorlin syndrome patient genomes. Mutations in PTCH1 gene were detected in all four patients. Specific nucleotide variations or frameshift variations of PTCH1 were identified along with the inferred amino acid changes in all patients. We further filtered 84 different genes which are closely related to Hh signaling. Fifty three of these had enough coverage of over ×30. The sequencing results were filtered and compared to reduce the number of sequence variants identified in each of the affected individuals. We discovered three genes, PTCH2, BOC, and WNT9b, with mutations with a predicted functional impact assessed by MutationTaster2 or PolyPhen-2 (Polymorphism Phenotyping v2) analysis. It is noticeable that PTCH2 and BOC are Hh receptor molecules. No significant mutations were observed in SUFU. Multi-layered mutations in Hh pathway may change the activation level of the Hh signals, which may explain the wide phenotypic variability of Gorlin syndrome.

Indexed as

ExomeMutationPhenotypeBasal Cell Nevus SyndromeFemaleHumansImmunoglobulin GMalePatched-1 ReceptorPatched-2 ReceptorReceptors, Cell SurfaceWnt ProteinsBOC protein, humanImmunoglobulin GPatched-1 ReceptorPatched-2 ReceptorPTCH1 protein, humanPTCH2 protein, humanReceptors, Cell SurfaceWNT9B protein, humanWnt Proteins

Identifiers

PMID28915250
PMCPMC5600381
OpenAlexW2755551844

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.